Found: 45
Select item for more details and to access through your institution.
Blood–Brain Barrier Disruption and Perivascular Spaces in Small Vessel Disease and Neurodegenerative Diseases: A Review on MRI Methods and Insights.
- Published in:
- Journal of Magnetic Resonance Imaging, 2024, v. 59, n. 2, p. 397, doi. 10.1002/jmri.28989
- By:
- Publication type:
- Article
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.
- Published in:
- JAMA Psychiatry, 2018, v. 75, n. 1, p. 84, doi. 10.1001/jamapsychiatry.2017.3391
- By:
- Publication type:
- Article
Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders.
- Published in:
- Translational Psychiatry, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41398-022-01817-0
- By:
- Publication type:
- Article
Amyloid Pathology, Cognitive Impairment, and Alzheimer Disease Risk--Reply.
- Published in:
- 2015
- By:
- Publication type:
- commentary
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 19, p. 1924, doi. 10.1001/jama.2015.4668
- By:
- Publication type:
- Article
Temporally ordered associations between type 2 diabetes and brain disorders – a Danish register-based cohort study.
- Published in:
- BMC Psychiatry, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12888-022-04163-z
- By:
- Publication type:
- Article
Predictors of preclinical Alzheimer's disease in persons with subjective cognitive decline: Neuropsychiatry and behavioral neurology/presymptomatic disease/prodromal disease/prodromal states.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042658
- By:
- Publication type:
- Article
Plasma amyloid‐beta42/40 ratio as biomarker of cerebral amyloidosis in cognitively unimpaired APOE‐e4 homozygotes, heterozygotes and non‐carriers: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.040332
- By:
- Publication type:
- Article
CSF Aβ42, P‐tau and noradrenaline metabolite MHPG levels are synergistically related to cortical thickness in a memory clinic population: Neuroimaging / Optimal neuroimaging measures for early detection.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.037481
- By:
- Publication type:
- Article
O5‐05‐03: ASSOCIATIONS BETWEEN CEREBROSPINAL FLUID NEURODEGENERATIVE MARKERS, NEUROFILAMENT‐LIGHT AND TOTAL TAU AND CEREBROVASCULAR IMAGING MARKERS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1626, doi. 10.1016/j.jalz.2019.06.4860
- By:
- Publication type:
- Article
P4‐219: THE AMYLOID BIOMARKER STUDY: A DATA SHARING INITIATIVE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1360, doi. 10.1016/j.jalz.2019.06.3882
- By:
- Publication type:
- Article
P3‐585: COGNITIVE RESERVE MODULATES THE ASSOCIATION OF CEREBRAL AMYLOID PATHOLOGY WITH COGNITIVE PERFORMANCE IN PERSONS WITH ALZHEIMER'S DISEASE DEMENTIA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1349, doi. 10.1016/j.jalz.2018.06.1951
- By:
- Publication type:
- Article
O2‐09‐06: FREQUENCIES OF CEREBROSPINAL FLUID A/T/N BIOMARKER PROFILES AND THEIR ASSOCIATION WITH MEMORY FUNCTION IN PERSONS WITHOUT DEMENTIA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P643, doi. 10.1016/j.jalz.2018.06.2693
- By:
- Publication type:
- Article
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 7, p. 913, doi. 10.1016/j.jalz.2018.02.009
- By:
- Publication type:
- Article
PREVALENCE OF THE APOLIPOPROTEIN E ε4 ALLELE IN AMYLOID-β POSITIVE SUBJECTS ACROSS THE SPECTRUM OF ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P515, doi. 10.1016/j.jalz.2017.06.591
- By:
- Publication type:
- Article
THE IMPACT OF AMYLOID AND TAU PATHOLOGY ON THE DEVELOPMENT OF SUBTLE COGNITIVE CHANGES IN PERSONS WITHOUT DEMENTIA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P912, doi. 10.1016/j.jalz.2017.07.334
- By:
- Publication type:
- Article
COGNITIVE CONSEQUENCES OF CEREBRAL AMYLOID PATHOLOGY IN PERSONS WITHOUT DEMENTIA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P307, doi. 10.1016/j.jalz.2016.06.556
- By:
- Publication type:
- Article
USING GENE EXPRESSION AND GENETICS TO PREDICT AMYLOID BURDEN BEFORE DEMENTIA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1157, doi. 10.1016/j.jalz.2016.07.065
- By:
- Publication type:
- Article
RELATION BETWEEN LIFESTYLE FACTORS AND ALZHEIMER'S DISEASE BIOMARKERS IN SUBJECTS WITH SCI OR MCI.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P294, doi. 10.1016/j.jalz.2016.06.532
- By:
- Publication type:
- Article
Prevalence of amyloid and neurodegeneration markers and effects on cognitive functioning in non-demented subjects.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P340, doi. 10.1016/j.jalz.2015.06.207
- By:
- Publication type:
- Article
The influence of severity of total comorbidity on cognitive decline and conversion to dementia in memory clinic visitors.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P260, doi. 10.1016/j.jalz.2015.07.334
- By:
- Publication type:
- Article
Effect of apoe genotype on the prevalence of amyloid pathology in non-demented subjects.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, p. P220, doi. 10.1016/j.jalz.2014.04.302
- By:
- Publication type:
- Article
Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data.
- Published in:
- Frontiers in Aging Neuroscience, 2018, p. N.PAG, doi. 10.3389/fnagi.2018.00193
- By:
- Publication type:
- Article
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 3, p. 228, doi. 10.1001/jamaneurol.2021.5216
- By:
- Publication type:
- Article
Editorial: Vascular Factors and Vascular Lesions in Pre-clinical Alzheimer's Disease.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
The association between depressive symptoms and amyloid positivity.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079771
- By:
- Publication type:
- Article
Cerebral microbleeds and amyloid pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079510
- By:
- Publication type:
- Article
Multiomics‐based prediction of trajectories of global cognitive functioning in the ADNI cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077394
- By:
- Publication type:
- Article
Prediction of longitudinal cortical amyloid deposition based on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively unimpaired individuals: the role of APOE‐ε4.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076943
- By:
- Publication type:
- Article
Ethnoracial differences in the prevalence of amyloid abnormality.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079159
- By:
- Publication type:
- Article
The association between diabetes measures and Alzheimer's disease biomarkers in CSF – A meta‐analysis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076750
- By:
- Publication type:
- Article
Smoking behavior, sleep quality, and physical activity level are associated with cerebral amyloid pathology in non‐demented persons: The Amyloid Biomarker Study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 1, doi. 10.1002/alz.065504
- By:
- Publication type:
- Article
Amyloid‐ß aggregation, APOE‐e genotype, and the trajectory of cognitive decline in persons without dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 7, p. 1, doi. 10.1002/alz.063055
- By:
- Publication type:
- Article
A synergistic association of diabetes and AD biomarkers on cognitive decline in persons without dementia?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.066490
- By:
- Publication type:
- Article
Associations of AD risk factors with cerebrospinal fluid ATN biomarker profiles in 10,662 persons without dementia from the Amyloid Biomarker Study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.065447
- By:
- Publication type:
- Article
Plasma neurofilament light chain in cognitively unimpaired late middle‐aged & older adult APOE ε4 homozygotes, heterozygotes, & non‐carriers from the Arizona APOE Cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.060091
- By:
- Publication type:
- Article
Characteristics of subjective cognitive decline associated with amyloid positivity.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1832, doi. 10.1002/alz.12512
- By:
- Publication type:
- Article
Updated prevalence estimates of amyloid positivity from cognitively normal to clinical Alzheimer's disease dementia: The Amyloid Biomarker Study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.054889
- By:
- Publication type:
- Article
Associations of lifestyle factors with amyloid positivity in cognitively normal individuals at different levels of genetic risk: The amyloid biomarker study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.054090
- By:
- Publication type:
- Article
The association between diabetes and Alzheimer's disease pathophysiology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.050181
- By:
- Publication type:
- Article
CSF amyloid‐beta, tau, and neurodegenerative and inflammatory biomarkers in cognitively unimpaired late middle‐aged and older adult APOE ε4 homozygotes, heterozygotes, and non‐carriers from the Arizona APOE Cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057242
- By:
- Publication type:
- Article
Locus coeruleus hypopigmentation is associated with an increased risk of cerebral microangiopathy in autopsy cases with cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.053974
- By:
- Publication type:
- Article
Predictors of preclinical Alzheimer's disease in persons with subjective cognitive decline: Neuropsychiatry and behavioral neurology/presymptomatic disease/prodromal disease/prodromal states.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 6, p. 1, doi. 10.1002/alz.042658
- By:
- Publication type:
- Article